ESPR vs AYTU โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ESPR Captures Institutional Edge (3โ1 Pillars ยท 8โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Esperion Therapeutics, Inc. (ESPR) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while AYTU counters with relative strength in Valuation. Fundamentally, ESPR trades at 10.9x Forward P/E with -8.2% operating margin (+23.2% YoY revenue) versus AYTU at 9.2x Forward P/E and -14.4% operating margin (+6.4% YoY). In options structure, ESPR sits in UNCLASSIFIED (9th %ile IV; Dealer Gamma Walls on Pro) against AYTU sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | ESPR Revenue | AYTU Revenue | ESPR Op. Margin | AYTU Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2019 | $150M | $10M | -62.8% | -230.1% | ESPR |
| FY2020 | $230M | $30M | -53.3% | -76.5% | ESPR |
| FY2021 | $80M | $70M | -289.0% | -89.7% | AYTU |
| FY2022 | $80M | $100M | -237.8% | -113.7% | AYTU |
| FY2023 | $120M | $110M | -133.7% | -15.9% | AYTU |
| FY2024 | $330M | $70M | 16.4% | -2.4% | ESPR |
| FY2025 | $400M | $70M | 15.0% | -11.8% | ESPR |
| FY2026 | N/A | $60M | N/A | -14.4% | AYTU |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ESPR | AYTU | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $822.0M | $19.6M | Larger Scale | ESPR |
| Trailing P/E Ratio Valuation | 4.6x | 9.2x | Lower Multiple | ESPR |
| Forward P/E Ratio Valuation | 10.9x | 9.2x | Lower Multiple | AYTU |
| Revenue Growth (YoY) Growth | +23.2% | +6.4% | Higher Growth | ESPR |
| Operating Margin (TTM) Profitability | -8.2% | -14.4% | Higher Margin | ESPR |
| Net Profit Margin Profitability | -1.8% | -24.8% | Higher Margin | ESPR |
| Return on Equity (ROE) Capital Efficiency | -260.8% | -52.5% | Higher ROE | AYTU |
| 52-Week Range Position Momentum | 68% ($1โ$4) | 5% ($2โ$3) | Stronger Trend | ESPR |
| Beta / 30D Volatility Risk Regime | 1.86ฮฒ ยท 6% Vol | 0.65ฮฒ ยท 35% Vol | Lower Realized Risk | ESPR |
| Unified Institutional Score Composite Signal | 60.0 / 100 (BUY) | 48.9 / 100 (HOLD) | Higher Composite | ESPR |